Ensysce Biosciences
Clinical trials sponsored by Ensysce Biosciences, explained in plain language.
-
New Opioid-Like drug aims to ease Post-Surgery pain
Symptom relief Recruiting nowThis study tests a new drug called PF614, a modified form of oxycodone, for people with moderate to severe pain after tummy tuck surgery. About 320 adults will take either the drug or a placebo every 12 hours for up to 4 days. Researchers will measure pain relief and watch for si…
Phase: PHASE3 • Sponsor: Ensysce Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New oxycodone combo aims to curb abuse – first human test underway
Knowledge-focused Recruiting nowThis early-stage trial tests how a new form of oxycodone (PF614) combined with nafamostat behaves in the body. Fifty-four healthy adults will receive single doses to measure drug levels and safety. The goal is to see if this combination can reduce misuse potential while still pro…
Phase: PHASE1 • Sponsor: Ensysce Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC